-

U.S. Erectile Dysfunction Industry Report 2020: Pipeline, Epidemiology, Key Products, Market Valuations & Forecast, Drugs Sales and Market Shares - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Erectile Dysfunction Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

The report provides comprehensive insights into Erectile Dysfunction pipeline products, Erectile Dysfunction epidemiology, Erectile Dysfunction market valuations and forecast, Erectile Dysfunction drugs sales and competitive landscape in the US.

The research is classified into seven sections - Erectile Dysfunction treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

  • Erectile Dysfunction pipeline: Find out the products in clinical trials for the treatment of Erectile Dysfunction by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Erectile Dysfunction epidemiology: Find out the number of patients diagnosed (prevalence) with Erectile Dysfunction in the US
  • Erectile Dysfunction drugs: Identify key products marketed and prescribed for Erectile Dysfunction in the US, including trade name, molecule name, and company
  • Erectile Dysfunction drugs sales: Find out the sales revenues of Erectile Dysfunction drugs in the US
  • Erectile Dysfunction market valuations: Find out the market size for Erectile Dysfunction drugs in 2019 in the US. Find out how the market advanced from 2016 and forecast to 2025
  • Erectile Dysfunction drugs market share: Find out the market shares for key Erectile Dysfunction drugs in the US

Benefits of this Research

  • Support monitoring and reporting national Erectile Dysfunction market analysis and sales trends
  • Track competitor drugs sales and market share in the US Erectile Dysfunction market
  • Track competitive developments in Erectile Dysfunction market and present key issues and learnings
  • Synthesize insights for Erectile Dysfunction market and products to drive business performance
  • Answer key business questions about the Erectile Dysfunction market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Erectile Dysfunction products
  • Supports decision making in R&D to long term marketing strategies

Key Topics Covered

1) Erectile Dysfunction Treatments

2) Erectile Dysfunction Pipeline

3) US Erectile Dysfunction Epidemiology

4) Marketed Drugs for Erectile Dysfunction in US

5) US Erectile Dysfunction Market Size and Forecast

6) US Erectile Dysfunction Products Sales and Forecast

7) US Erectile Dysfunction Market Competitive Landscape

8) Methodology

List of Tables

1. Erectile Dysfunction Phase 3 Clinical Trials, 2020

2. Erectile Dysfunction Phase 2 Clinical Trials, 2020

3. Erectile Dysfunction Phase 1 Clinical Trials, 2020

4. Erectile Dysfunction Epidemiology, US, 2016 - 2025

5. Marketed Drugs for Erectile Dysfunction, US, 2019

6. Erectile Dysfunction Market Size and Forecast ($), US, 2016 - 2025

7. Erectile Dysfunction Product Sales ($), US, 2016 - 2025

List of Figures

1. Erectile Dysfunction Epidemiology, US, 2016 - 2025

2. Erectile Dysfunction Market Size and Forecast ($), US, 2016 - 2025

3. Erectile Dysfunction Products Market Share (%), US, 2019

For more information about this report visit https://www.researchandmarkets.com/r/ylzawm

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

1 Day Clinical Trial Agreements Training Course: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets (Mar 18, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Agreements: Key Legal, Regulatory and IP (Intellectual Property) Considerations for the EU (European Union) and UK Markets Training Course (Mar 18, 2026)" training has been added to ResearchAndMarkets.com's offering. The life sciences sector is heavily regulated and CTAs are some of the most important agreements for companies operating in this sector. Having appropriate CTAs in place is therefore essential for managing relationships between the diffe...

Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Understand the regulatory frameworks governing drug/device and device/drug combinations in the European Union and the USA. The demarcation between medicinal products and devices is becoming ever more important and, with the conve...

Wedding Rings Market Trends, Shares and Growth Prospects 2025-2030 - Cultural and Social Trends Around Minimalism and Modern Design Drive Adoption of Non-Traditional Styles - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Wedding Rings - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Wedding Rings was valued at US$56.7 Billion in 2024 and is projected to reach US$80.7 Billion by 2030, growing at a CAGR of 6.1% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The wedding ring market is expanding due to a combin...
Back to Newsroom